Strona główna・Stock List・Inmode Ltd

Inmode Ltd

Closed

SectorHealthcare

14.99 -1.06

Buy Sell

Overview

Share price change

24h

Current

Min

14.94

Max

15.15

Key metrics
By Trading Economics
Income	5.5M 17M
Sales	14M 96M
P/E Sector Avg	12.658 57.002
EPS	0.29
Profit margin	17.851
Employees	660
EBITDA	-2.1M 12M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+5.61% upside

Dividends
By Acuity
Next Earnings	4 lis 2026

Market Stats
By TradingEconomics
Market Cap	-9.2M 873M
Previous open	16.05
Previous close	14.99

News Sentiment

By Acuity

50%

146 / 340 Ranking in Healthcare

Inmode Ltd Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 sie 2026, 21:02 UTC

Inmode Ltd is modestly higher in after-market trading, maintaining a steady price level. No specific company news was identified to explain the movement.

13 sie 2026, 19:46 UTC

Inmode Ltd. shares are lower today amid routine fluctuations and rising initial jobless claims, reflecting overall soft market conditions.

12 sie 2026, 21:41 UTC

Inmode Ltd shares are lower in after-market hours, following a routine decline since Wednesday's close. No specific news was identified to explain the drop.

6 sie 2026, 19:46 UTC

Inmode Ltd. shares are lower today, continuing a trend amid broader market weakness and rising crude oil prices alongside increasing bond yields.

5 sie 2026, 23:11 UTC

Inmode Ltd is trading higher in after-market hours, reflecting broader market gains. No specific company news was identified to explain the movement.

30 lip 2026, 18:56 UTC

Inmode Ltd shares are lower, influenced by declines in the Health Care Equipment sub-sector. The stock has traded lower since Wednesday's close.

29 lip 2026, 19:55 UTC

Inmode Ltd shares are lower Wednesday, continuing a decline since Tuesday's close amid broader market pressure from rising crude oil prices and inflation concerns.

28 lip 2026, 22:51 UTC

News

Inmode Ltd shares declined in after-market hours as Steel Partners urged shareholders to reject proposals, citing governance concerns and excessive compensation.

22 lip 2026, 19:16 UTC

Inmode Ltd shares are lower amid rising crude oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

21 lip 2026, 15:46 UTC

Inmode Ltd shares are lower Tuesday, extending a decline after three consecutive daily closes. The stock opened with a notable dip before recovering slightly.

20 lip 2026, 19:26 UTC

News

InMode Ltd faces scrutiny from Bronstein, Gewirtz & Grossman, LLC, over governance issues, contributing to a decline in its stock price since Friday's close.

Peer Comparison

Price change

Inmode Ltd Forecast

Price Target

By TipRanks

5.61% upside

12 Months Forecast

Average 16 USD 5.61%

High 17 USD

Low 15 USD

Based on 4 Wall Street analysts offering 12 month price targets forInmode Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

4 ratings

Buy

Hold

Sell

Based on 4 analysts giving stock ratings to Inmode Ltd - Dist in the past 3 months.

Sentiment

By Acuity

146 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.